Rxsight Inc Total Liabilities
Rxsight Inc total liabilities. Based on the latest financial reports, Rxsight Inc (RXST) has total liabilities worth $89.36 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Rxsight Inc (RXST) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Rxsight Inc (2019–2025)
Total liabilities of Rxsight Inc from 2019 to 2025. This chart illustrates how Rxsight Inc's total liabilities have evolved over time, based on quarterly financial data.
Rxsight Inc Competitors by Total Liabilities
The table below lists competitors of Rxsight Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
HD Renewable Energy Co. Ltd.
TW:6873
|
Taiwan | NT$9.25 Billion |
|
Nordic Aqua Partners As
OL:NOAP
|
Norway | Nkr85.46 Million |
|
SES AI Corp
NYSE:SES
|
USA | $50.27 Million |
|
Aprogen Healthcare & Games Inc
KQ:109960
|
Korea | ₩15.37 Billion |
|
Cloud Live Technology Group Co Ltd
SHE:002306
|
China | CN¥730.26 Million |
|
Newegg Commerce Inc
NASDAQ:NEGG
|
USA | $251.30 Million |
|
Pyrophyte Acquisition Corp. II
NYSE:PAII
|
USA | $9.56 Million |
|
Yesco Holdings Co. Ltd
KO:015360
|
Korea | ₩710.54 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down Rxsight Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Rxsight Inc's balance sheet.
Liquidity & Leverage Metrics
Rxsight Inc Total Liabilities Ratios Explained
Rxsight Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Rxsight Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Rxsight Inc (2019–2025)
The table below shows the annual total liabilities of Rxsight Inc from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $36.13 Million | -3.20% |
| 2024-12-31 | $37.33 Million | +68.22% |
| 2023-12-31 | $22.19 Million | -63.18% |
| 2022-12-31 | $60.26 Million | +10.62% |
| 2021-12-31 | $54.48 Million | -86.32% |
| 2020-12-31 | $398.21 Million | -4.06% |
| 2019-12-31 | $415.04 Million | -- |
About Rxsight Inc
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adju… Read more